Literature DB >> 15106026

Burden of illness imposed by severe sepsis in Switzerland.

A Schmid1, J Pugin, J-C Chevrolet, S Marsch, S Ludwig, R Stocker, H Finnern.   

Abstract

OBJECTIVE: This study aims to determine the burden of illness imposed by severe sepsis in Switzerland by evaluating the direct and indirect patient-related costs for critically ill patients with severe sepsis.
METHODS: In order to estimate the direct costs a retrospective analysis was undertaken using records from 61 adult patients treated in three intensive care units (ICUs) in three different University hospitals in Switzerland, in 2001. Resource use was determined by a bottom up approach and valued using centre-specific unit costs for medication, nutrition, blood products, disposables and official tariffs for laboratory and microbiology analysis, diagnostic services, and clinical procedures. By adding centre-specific personnel and basic bed (hotel) costs total direct costs in the ICU were calculated. Indirect costs resulting from unfitness for work, early retirement, and premature death were calculated using official Swiss statistics for the years 1998-2000.
RESULTS: The mean total direct costs for a severely septic patient are CHF 41,790 (+/- 33,222 CHF) or CHF 3244 (+/- 757 CHF) per day. Nonsurvivors cause significantly higher costs than survivors (CHF 45,956 vs. CHF 37,759, p <0.001). The total intensive care costs in Switzerland due to severe sepsis amount to CHF 146-355 million. Indirect costs were estimated to range from CHF 347 to 844 million (predominantly due to premature death). Consequently the burden of illness of severe sepsis can be estimated to range from CHF 493 to 1199 million per year in Switzerland (1 CHF = 0.662 Euro in 2001).
CONCLUSION: Patients suffering from severe sepsis in Switzerland have a high mortality rate and spend a prolonged time in the ICU, leading to high direct and indirect costs. Particularly productivity losses due to premature death represent a considerable burden to the Swiss society.

Entities:  

Mesh:

Year:  2004        PMID: 15106026     DOI: 2004/07/smw-10475

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  11 in total

Review 1.  The Economic and Humanistic Burden of Severe Sepsis.

Authors:  Bogdan Tiru; Ernest K DiNino; Abigail Orenstein; Patrick T Mailloux; Adam Pesaturo; Abhinav Gupta; William T McGee
Journal:  Pharmacoeconomics       Date:  2015-09       Impact factor: 4.981

2.  The socio-economic impact of work disability due to inflammatory bowel disease in Brazil.

Authors:  Renata de S B Fróes; Ana Teresa Pugas Carvalho; Antonio Jose de V Carneiro; Adriana Maria Hilu de Barros Moreira; Jessica P L Moreira; Ronir R Luiz; Heitor S de Souza
Journal:  Eur J Health Econ       Date:  2017-05-18

Review 3.  [The cost of sepsis].

Authors:  O Moerer; H Burchardi
Journal:  Anaesthesist       Date:  2006-06       Impact factor: 1.041

Review 4.  Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes.

Authors:  Greg S Martin
Journal:  Expert Rev Anti Infect Ther       Date:  2012-06       Impact factor: 5.091

5.  Effects of the PARP Inhibitor Olaparib on the Response of Human Peripheral Blood Leukocytes to Bacterial Challenge or Oxidative Stress.

Authors:  Sidneia Sousa Santos; Milena Karina Coló Brunialti; Larissa de Oliveira Cavalcanti Peres Rodrigues; Ana Maria Alvim Liberatore; Ivan Hong Jun Koh; Vanessa Martins; Francisco Garcia Soriano; Csaba Szabo; Reinaldo Salomão
Journal:  Biomolecules       Date:  2022-06-04

6.  Early sepsis does not stimulate reactive oxygen species production and does not reduce cardiac function despite an increased inflammation status.

Authors:  Thibault Léger; Alice Charrier; Clarisse Moreau; Isabelle Hininger-Favier; Evangelia Mourmoura; Jean-Paul Rigaudière; Elodie Pitois; Damien Bouvier; Vincent Sapin; Bruno Pereira; Kasra Azarnoush; Luc Demaison
Journal:  Physiol Rep       Date:  2017-07

7.  Epidemiological trends of sepsis in the twenty-first century (2000-2013): an analysis of incidence, mortality, and associated costs in Spain.

Authors:  Alejandro Álvaro-Meca; María A Jiménez-Sousa; Dariela Micheloud; Ainhoa Sánchez-Lopez; María Heredia-Rodríguez; Eduardo Tamayo; Salvador Resino
Journal:  Popul Health Metr       Date:  2018-02-12

Review 8.  The "Centrality of Sepsis": A Review on Incidence, Mortality, and Cost of Care.

Authors:  Jihane Hajj; Natalie Blaine; Jola Salavaci; Douglas Jacoby
Journal:  Healthcare (Basel)       Date:  2018-07-30

9.  The Economic Burden of Stroke Based on South Korea's National Health Insurance Claims Database.

Authors:  Yu-Jin Cha
Journal:  Int J Health Policy Manag       Date:  2018-10-01

10.  Chronic Toxoplasma gondii Infection Exacerbates Secondary Polymicrobial Sepsis.

Authors:  Maria C Souza; Denise M Fonseca; Alexandre Kanashiro; Luciana Benevides; Tiago S Medina; Murilo S Dias; Warrison A Andrade; Giuliano Bonfá; Marcondes A B Silva; Aline Gozzi; Marcos C Borges; Ricardo T Gazzinelli; José C Alves-Filho; Fernando Q Cunha; João S Silva
Journal:  Front Cell Infect Microbiol       Date:  2017-04-07       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.